Share on

Global Clinical Nutrition Market Size, Share, Trends, COVID-19 Impact and Growth Analysis Report – Segmented By Route of Administration, Therapeutic Areas, Ingredients Type and Region – Industry Forecast (2022 to 2027).

Published: January, 2022
ID: 727
Pages: 179
Formats: report pdf report excel report power bi report ppt

Clinical Nutrition Market Size (2022 to 2027)

As per the report, the size of the global clinical nutrition market is projected to grow from USD 14.58 Billion in 2022 to USD 17.85 Billion by 2027. This market is estimated to grow at a CAGR of 4.13% during the forecast period.

Some of the key insights from the report:

  • Based on the  Route of Administration, the oral clinical nutrition segment dominated the global market and captured the largest market share in 2021.
  • Based on Therapeutic Areas, the Diabetes segment is expected to lead the market during the forecast period.
  • The North American Clinical nutrition market is expected to be worth USD 5.91 billion by 2027
  • The Asia Pacific clinical nutrition market, showcased the highest CAGR of  6.02% during the forecast period. 

Clinical nutrition aids in improving absorption, metabolism, digestion, and discharge functions by providing essential nutrients such as minerals, vitamins, and proteins. These products are vital for patients with a high degree of malnourishment, patients in intensive care units, patients recovering from trauma or surgery, and patients suffering from chronic diseases. In addition, it has been found that treating disease-related malnutrition with clinical nutrition therapies can reduce mortality.

Clinical nutrition is necessary for patients facing nutritional deficiency or unable to consume food due to enhanced disease conditions, leading to lower quality of life, complications, increased risk of mortality, and lengthening of a recovery period. In addition, clinical nutrition plays a vital role in maintaining nutritional imbalance for malnourished pawithho who have a higher risk of complications because of a lack of nutrition.

Impact of COVID-19 on the global clinical nutrition market:

The SARS-CoV-2 (COVID-19) pandemic has rocked the pillars of our culture and, indeed, our healthcare system. COVID-19 has been characterized by diverse clinical presentations that have not yet been fully understood. In addition to marked respiratory symptoms, the virus induces a disproportionate immune response in certain people with severe allergic reactions. Since the onset of the pandemic, older people and patients with various illnesses have been reported as the most seriously affected patients, reflecting standard risk categories for malnutrition. The infection also causes a severe lack of appetite and other symptoms such as anosmia, dysgeusia, or diarrhea, both of which raise the risk of disease-related malnutrition (DRM). Acute malnutrition caused by Covid-19 infection would also be associated with an increased loss of muscle mass and a deterioration of immune defenses that would lead to the severity of COVID-19. Moreover, some of the medications used in the treatment can exacerbate these effects, as in the case of the dial; all these situations can enhance the growth of the clinical nutrition market.

Post the loc, down; many companies came up with new clinical nutritious products to improve the physical and mental health of individuals concerning the COVID-19 pandemic to preserve adequate nutrition at the personal, household, national and global levels, using U.K.U.K.K.K.K.daptU.K. version of the ecological model of health behavior like clinical nutrition products. In addition, many initiatives takeU.S.U.S.U.S.U.S.U.S.aseU.S.wareness regarding nutrition across the globe. For example, an online initiative calls for improved vitamin C supplementation in the battle against COVID-19. Its petition is reportedly signed by more than 100 physicians and 200 nutritionists, calling on the U.K. Government and its public health and nutrition departments to prescribe vitamin C supplements to all people during the pandemic, and the U.S. Natural Products Association (NPA) continues to stress the importance of keeping health food stores open in California.

Besides, there are many challenges faced by nutritionists that encounter during this pandemic. For excountries must now have sufficient human capital resources ample, to meet the different agencies' COVID-19 diet guidelines outlined in nutrition sources. But still, there are some regions a shortage of human capital in the provision of clinical nutrition is likely to be high on the list of challenges. Also, as dietitians are frequently not permitted to access COVID-19 hospitals, clinical nutrition teams need to write and introduce new nutrition guidelines to ensure that nutrition screening and appraisal remain a priority.


The rising incidence of metabolic disorders and increased healthcare expenditure favor the growth of the global clinical nutrition market.

The prevalence of metabolic diseases has risen in raw evidence over the last decade; the number of people choosing to diagnose metabolic conditions has increased over the past decade, resulting in a rise in the number of patients diagnosed. As a result, with the growing incidence of metabolic disorders, there is an excellent potential for clinical nutrition industry participants to access emerging markets and establish their presence. In addition, increasing numbers of people suffering from chronic disorders such as cancer and diabetes, combined with an increasing geriatric population, a growing obese population due to unsanitary eating behaviors, and physical inactivity, increasing the rate of premature births increases the growth of the global clinical nutrition market.

It has also been noted that healthcare spending tends to rise faster than economic growth in most nations, continuing the pattern observed over the decU.S.esU.S.CoU.S.equenU.S.y, as healthcare U.S.endiU.S. is growing across the world's major countries, the clinical nutrition market is projected to grow due to its broad applicability. As a result, there is a range of investment opportunities for clinical nutrition from countries worldwide, including private foundations and the international community. Significant supporting agencies include the National Institutes of Health, the U.S. Department of Agriculture, the Robert Woods Johnson Foundation, and the Nestle Foundation. These financing opportunities have been established to promote the development of the business examined.

Additionally, the expansion of the healthcare sector, the emergence of innovative products into the market, awareness programs by private and public institutions, the high occurrence of neurological diseases, and reimbursement policies are expected to propel growth opportunities for the clinical nutrition market.


The need to make up for nuU.S.tioU.S. thU.S.pies' U.S.ety and quality stanU.S.ds isU.S.restraint for the global clinical nutrition market. Additionally, strict guidelines related to nutrition supplements and less knowledge among emerging countries like India and China are expected to hamper market growth slightly. Clinical nutritional products are considered pharmaceutical products. Therefore, the manufacturers should follow the guidelines set by the U.S. Food and Drug Administration and the European Medicines Agency (EMA) in Europe. The difficulties associated with getting approvals from the government authorities are significant challenging factors. 




Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Covered

By Route Of Administration, Therapeutic Areas, Ingredients Type, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa


This market research report on the global clinical nutrition market has been segmented based on the route of administration, therapeutic areas, ingredients type, and region.

Clinical Nutrition Market - By Route of Administration:

  • Oral Nutrition
  • Enteral Nutrition
  • Parenteral Nutrition

Based on the administration route, oral clinical nutrition sdominatesinating the market as the Enteral and parenteral segments are expensive due to expenses involving the pricing of nutrients or products. As a result, the oral segment accounted for the largest share in 2020 and is expected to continue the trend throughout the forecast period. This growth is attributed to its extensive usage in patients owing to its easy intake and availability for several diseases.

Clinical Nutrition Market - By Therapeutic Areas:

  • Malabsorption
  • Diarrhea
  • Cancer
  • Food Allergies
  • Maldigestion
  • Diabetes
  • Short-Bowel Syndrome
  • Acute Lung Injury
  • Acute Respiratory Distress

Based on therapeutic areas, the Diabetes segment is ruling the clinical nutrition market owing increase in the rate of diabetic patients in recent On the other hand, others. The cancer market is segmeproliferatingrapidly with a high CAGR and is expected to contribute significantly during the forecast period.

The cancer segment is projected to be the fastest-growing segment during the forecast period. It is attributed to the nutritional deficiency in patients due to various cancer treatments such as chemotherapy, hormone therapy, radiation therapy, surgery, immunotherapy, and stem cell transplant.

Clinical Nutrition Market - By Ingredients Type:

  • Vitamins
  • Minerals
  • Carbohydrates
  • Amino Acids

Based on ingredients type, the Vitamins segment contribsignificantlyshare to the clinical nutrition market and is expected to grow further during the forecast period.

Clinical Nutrition Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, the Clinical Nutrition market in North America and Europe was rapidly growing due to the high malnutrition rate and increased U.S.latU.S.affU.S.d of varU.S. U.S.h America was the leading revenue contributor to the global clinical nutrition market in 2020 and is anticipated to dominate the market during the forecast period due to an upsurge in several chronic diseases such as coronary artery disease, ischemic stroke, diabetes, and a few cancer indications, and increase in the geriatric population. Besides, the initiative taken by the U.S. government to promote complete nutrition care for cancer patients is anticipated to drive the market further. However, Asia-Pacific is expected to experience the fastest CAGR during the forecast period due to increased metabolic disorders, high disposable incomes, and patient awareness regarding adopting clinical nutrition products.

The Asia Pacific region is ruling the Global Clinical nutrition market by contributing a significant share in revenue due to increased birth rates, a rise in the geriatric population, increasing chronic conditions in patients, and unhealthy food habits.

In the forecast period, Asia-Pacific has the highest growth compared to the other regions. The significant factors contributing to the development of the Asia Pacific clinical nutrition market include an increase in the prevalence of metabolic disorders, a rise in the geriatric population in the Asia Pacific Region, and high healthcare. In addition, hits. The incidence of diabetes in China isproliferatingapidly, a significant factor for obesity. As per the International Diabetes Federation (IDF) data, there were over 114,394,800 cases of diabetes in China in 2017, and the rate of prevalence of diabetes in adults is 10.9%. In addition, the number of patients undergoing diagnosis of metabolic disorders has increased over the decade; hence, there is an increase in the number of patients diagnosed in the Asia Pacific region.

The size of the Clinical Nutrition market in Europe was worth USD 3.56 Billion in 2020 and is estimated to be growing at a CAGR of 7.17 % to reach USD 5.03 Billion by 2025. The European clinical nutrition market is driven by the aging population and increased disease diagnoses.

Japan's market is estimated to expand with a CAGR of 7.9% over the forecast period, owing to a large geriatric population base and increasing incidences of chronic conditions, including diabetes mellitus and cancer, due to dietary shifts. In addition, the presence of associations such as the Japan Society of Nutrition and Food Science (JSNFS), working towards promoting public health and creating awareness about clinical nutrition, will favor the growth of the Japanese market over the forecast timeframe.

Brazil's market dominated Latin America and was valued at around USD 1,586.6 million. However, the increasing obese population and the growing incidences of chronic diseases will drive the market growth ceases. In addition, the high prevalence of preterm births leading to a rise in demand for clinical nutrition will favor Brazil's market growth. Moreover, a strong association with the American Society of Parenteral and Enteral Nutrition helps develop the clinical nutrition market in the country.

The presence of associations such as the South African Society for Enteral and Parenteral Nutrition, creating awareness about clinical nutrition in the country, and the growing burden of enfeebling diseases will drive the South African market over the forecast timeframe. In addition, health infrastructure development and the increasing public and private player initiatives to boost sales of nutritional formulae in the country will propel market growth.


Some of the key market participants in the global clinical nutrition market profiled in this report are Nestle Nutrition, Abbott Laboratories Inc., Gentiva Health Services Inc., Mead Johnson & Company, Kendall, Ajinomoto Co. Inc., Hospira Inc., Hero Nutritionals Inc., Lonza Ltd, Baxter International Inc., B. Braun Melsungen AG, H., J. Heinz Company, American Home Patient Inc. and Fresenius Kabi.

Most companies concentrate on strategic tactics, such as mergers, partnerships, acquisitions, and others, to achieve a higher share of the global market while still seeking to strengthen their product portfolio. In addition, a scaling understanding of clinical nutrition has fuelled the market for adult and pediatric dietary formulations, with players trying to develop food alternatives that satisfy all the needs of the target population worldwide.


  • In 2019, Nestle acquired Persona to expand its product portfolio in personalized nutrition.
  • In 2019, Fresenius Medical care completed the acquisition of NxStage Medical.
  • In 2018, Nestle bought the rights to distribute food servicee products and consumer packaged goods from Starbucks Corporation.

Please wait. . . . Your request is being processed


How big is the global clinical nutrition market?

The global clinical nutrition market size is forecasted to be worth USD 14.58 billion in 2022 and USD 17.85 billion by 2027.

Does this report include the impact of COVID-19 on the clinical nutrition market?

Yes, we have studied and included the COVID-19 impact on the global clinical nutrition market in this report.

Which region led the clinical nutrition market in 2021?

Geographically, the North American regional market dominated the clinical nutrition market in 2021.

Which are the major players operating in the clinical nutrition market?

Nestle Nutrition, Abbott Laboratories Inc., Gentiva Health Services Inc., Mead Johnson & Company, Kendall, Ajinomoto Co. Inc., Hospira Inc., Hero Nutritionals Inc., Lonza Ltd, Baxter International Inc., B. Braun Melsungen AG, H., J. Heinz Company, American Home Patient Inc. and Fresenius Kabi are a few of the noteworthy players in the global clinical nutrition market.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample